[Prevention of cardiac rhythm disorders caused by intubation in cyclopropane].
D001145:Arrhythmias, Cardiac / Q000209:etiology*; D053840:Brugada Syndrome; D000075224:Cardiac Conduction System Disease; D002746:Chlorpromazine / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000009:adverse effects*; D006329:Heart Conduction System; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007440:Intubation; D010640:Phenothiazines / Q000031:analogs & derivatives
D003521:Cyclopropanes; D006634:Histamine H1 Antagonists; D010640:Phenothiazines; C030797:cyclopropane; C031637:phenothiazine; D002746:Chlorpromazine
ANTIHISTAMINICS/therapeutic use; ARRHYTHMIA/etiology and pathogenesis; CHLORPROMAZINE/therapeutic use; CYCLOPROPANE/injurious effects; PHENOTHIAZINE/related compounds
Die Verhütung von Herz-Rhythmusstörungen bei der Intubation in Cyclopropannarkose.